Anesthetic Influence on Electroconvulsive Therapy: A Comprehensive Review

References

• Smith K. Mental health: a world of depression. Nature. 2014;515(7526):181.
   PubMedGoogle Scholar
• Bodnar A, Krzywotulski M, Lewandowska A, et al. Electroconvulsive therapy and cognitive functions in treatment-resistant depression. World J Biol Psychiatry. 2015;17(2):159–164. doi:10.3109/15622975.2015.1091501
   PubMedGoogle Scholar
• Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depression Anxiety. 2010;27(1):78–89. doi:10.1002/da.20580
   PubMed Web of Science ®Google Scholar
• Mrazek DA, Hornberger JC, Altar CA, Degtiar I. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatric Serv. 2014;65(8):977–987. doi:10.1176/appi.ps.201300059
   PubMed Web of Science ®Google Scholar
• Turner EH. Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. Lancet Psychiatry. 2019;6(12):977–979. doi:10.1016/S2215-0366(19)30394-3
   PubMed Web of Science ®Google Scholar
• Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ect. 2004;20(1):13–20. doi:10.1097/00124509-200403000-00004
   PubMed Web of Science ®Google Scholar
• Espinoza RT, Kellner CH. Electroconvulsive Therapy. New Engl J Med. 2022;386(7):667–672. doi:10.1056/NEJMra2034954
   PubMed Web of Science ®Google Scholar
• Ninke T, Bayerl S, Groene P. Anesthesia for electroconvulsive therapy. Der Anaes. 2021;70(4):271–279. doi:10.1007/s00101-020-00831-5
   PubMedGoogle Scholar
• Koitabashi T, Oyaizu T, Ouchi T. Low bispectral index values following electroconvulsive therapy associated with memory impairment. J Anesth. 2009;23(2):182–187. doi:10.1007/s00540-008-0722-3
   PubMedGoogle Scholar
• Lin CY, Chen IM, Tsai HJ, Wu CS, Liao SC. Effectiveness of electroconvulsive therapy on treatment-resistant depressive disorder: a population-based mirror-image study. J Psychiatr Res. 2020;121:101–107.
   PubMedGoogle Scholar
• Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psych Scand. 2020;141(4):304–315. doi:10.1111/acps.13134
   PubMed Web of Science ®Google Scholar
• Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005. 2000(2):Cd000076 doi:10.1002/14651858.CD000076.pub2..
   Google Scholar
• Saito S. Anesthesia Management for Electroconvulsive Therapy. J Anes. 2005;19(2):142–149. doi:10.1007/s00540-004-0288-7
   PubMedGoogle Scholar
• Kadiyala PK, Kadiyala LD. ECT: a new look at an old friend. Current Opinion Anaes. 2018;31(4):453–458. doi:10.1097/ACO.0000000000000615
   PubMedGoogle Scholar
• Shahin O, Gohar SM, Ibrahim W, et al. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT). International J Clini Prac. 2022;26(4):370–375. doi:10.1080/13651501.2022.2035770
   Google Scholar
• Kato N. Neurophysiological mechanisms of electroconvulsive therapy for depression. Neuro Res. 2009;64(1):3–11. doi:10.1016/j.neures.2009.01.014
   Google Scholar
• Pfleiderer B, Michael N, Erfurth A, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res Neuroim. 2003;122(3):185–192. doi:10.1016/S0925-4927(03)00003-9
   PubMed Web of Science ®Google Scholar
• Njau S, Joshi SH, Espinoza R, et al. Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression. J Psychiatry Neurosci. 2017;42(1):6–16. doi:10.1503/jpn.150177
   PubMed Web of Science ®Google Scholar
• Xia M, Wang J, Sheng J, et al. Effect of Electroconvulsive Therapy on Medial Prefrontal γ-Aminobutyric Acid Among Schizophrenia Patients. J ECT. 2018;34(4):227–232. doi:10.1097/YCT.0000000000000507
   PubMedGoogle Scholar
• Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and Electroconvulsive Therapy. J ECT. 2014;30(2):116–121. doi:10.1097/YCT.0000000000000138
   PubMedGoogle Scholar
• Yatham LN, Liddle PF, Lam RW, et al. Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression. Br J Psychiatry. 2018;196(6):474–479. doi:10.1192/bjp.bp.109.069567
   Google Scholar
• Landau AM, Phan J-A, Iversen P, et al. Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression. Neuropharmacology. 2015;91:97–102. doi:10.1016/j.neuropharm.2014.12.025
   PubMed Web of Science ®Google Scholar
• Lillethorup TP, Iversen P, Wegener G, Doudet DJM, Landau AM. α2-adrenoceptor binding in Flinders-sensitive line compared with Flinders-resistant line and Sprague-Dawley rats. Acta Neuropsychiatr. 2015;27(6):345–352. doi:10.1017/neu.2015.24
   PubMedGoogle Scholar
• Kobayashi K, Imoto Y, Yamamoto F, et al. Rapid and lasting enhancement of dopaminergic modulation at the hippocampal mossy fiber synapse by electroconvulsive treatment. J Neurophysiol. 2017;117(1):284–289. doi:10.1152/jn.00740.2016
   PubMedGoogle Scholar
• Rush G, O’Donovan A, Nagle L, et al. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy. J Affective Disorders. 2016;205:60–68. doi:10.1016/j.jad.2016.06.035
   PubMed Web of Science ®Google Scholar
• Freire TFV, Rocha NSD, Fleck MPA. The association of electroconvulsive therapy to pharmacological treatment and its influence on cytokines. J Psychiatr Res. 2017;92:205–211. doi:10.1016/j.jpsychires.2017.05.004
   PubMed Web of Science ®Google Scholar
• Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P. Raised Plasma Levels of Tumor Necrosis Factor α in Patients With Depression:Normalization During Electroconvulsive Therapy. J ECT. 2003;19(4):183–188. doi:10.1097/00124509-200312000-00002
   PubMed Web of Science ®Google Scholar
• Luccarelli J, McCoy TH, Seiner SJ, Henry ME. Changes in seizure duration during acute course electroconvulsive therapy. Brain Stimulation. 2021;14(4):941–946. doi:10.1016/j.brs.2021.05.016
   PubMed Web of Science ®Google Scholar
• Jarineshin H, Kashani S, Fekrat F, et al. Seizure Duration and Hemodynamic State During Electroconvulsive Therapy: sodium Thiopental Versus Propofol. Global J Health Sci. 2015;8(2):126–131. doi:10.5539/gjhs.v8n2p126
   PubMedGoogle Scholar
• Nishihara F, Saito S. Adjustment of anaesthesia depth using bispectral index prolongs seizure duration in electroconvulsive therapy. Anaes Inten Care. 2004;32(5):661–665. doi:10.1177/0310057X0403200509
   PubMedGoogle Scholar
• Kranaster L, Hoyer C, Janke C, Sartorius A. Bispectral Index Monitoring and Seizure Quality Optimization in Electroconvulsive Therapy. Pharmacopsychiatry. 2013;46(04):147–150. doi:10.1055/s-0032-1331748
   PubMedGoogle Scholar
• Zahavi GS, Dannon P. Comparison of anesthetics in electroconvulsive therapy: an effective treatment with the use of propofol, etomidate, and thiopental. Neuropsychiatr Dis Treat. 2014;10:383–389. doi:10.2147/NDT.S58330
   PubMed Web of Science ®Google Scholar
• Mahmoodiyeh B, Modir H, Shayganfard M, Abdus A, Almasi-Hashiani A. Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial. Med Gas Res. 2023;13(3):112. doi:10.4103/2045-9912.350860
   PubMedGoogle Scholar
• Kumar A, Sharma D, Mani R. A comparison of propofol and thiopentone for electroconvulsive therapy. J Anaesthesiol Clin Pharmacol. 2012;28(3):353. doi:10.4103/0970-9185.98337
   PubMedGoogle Scholar
• Hussain Mir A, Shah NF, Din MU, Langoo SA, Reshi FA. Effectiveness of sodium thiopentone, propofol, and etomidate as an ideal intravenous anesthetic agent for modified electroconvulsive therapy. Saudi J Anaesth. 2017;11(1):26–31. doi:10.4103/1658-354X.197339
   PubMedGoogle Scholar
• Butterfield NN, Graf P, Macleod BA, Ries CR, Zis AP. Propofol reduces cognitive impairment after electroconvulsive therapy. J ect. 2004;20(1):3–9. doi:10.1097/00124509-200403000-00002
   PubMedGoogle Scholar
• Dannon P, Zahavi G. Comparison of anesthetics in electroconvulsive therapy: an effective treatment with the use of propofol, etomidate, and thiopental. Neuropsychiatr Dis Treat. 2014;1:383.
   Google Scholar
• Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. A Comparison of Propofol and Thiopentone Use in Electroconvulsive Therapy: cognitive and Efficacy Effects. J ECT. 2007;23(3):158–162. doi:10.1097/yct.0b013e318070d1e9
   PubMedGoogle Scholar
• Kavakbasi E, Stoelck A, Wagner NM, Baune BT. Differences in Cognitive Adverse Effects and Seizure Parameters Between Thiopental and Propofol Anesthesia for Electroconvulsive Therapy. J ect. 2023;39(2):97–101. doi:10.1097/YCT.0000000000000893
   PubMedGoogle Scholar
• Zivot JB. The absence of cruelty is not the presence of humanness: physicians and the death penalty in the United States. Philos Human Med. 2012;7(1):13. doi:10.1186/1747-5341-7-13
   Google Scholar
• Lammeren A, Dols A, van de Ven PM, et al. Etomidate and Seizure Duration in Electroconvulsive Therapy. J ECT. 2013;29(2):101–105. doi:10.1097/YCT.0b013e31827a7ebb
   PubMedGoogle Scholar
• Hoyer C, Kranaster L, Janke C, Sartorius A. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. European Arch Psych Clini Neuro. 2013;264(3):255–261. doi:10.1007/s00406-013-0420-5
   PubMedGoogle Scholar
• Ninke T, Groene P. Electroconvulsive therapy: recent advances and anesthetic considerations. Current Opinion Anaes. 2023;36(4):441–446. doi:10.1097/ACO.0000000000001279
   PubMedGoogle Scholar
• Rosa MA, Rosa MO, Belegarde IMT, Bueno CR, Fregni F. Recovery after ECT: comparison of propofol, etomidate and thiopental. Rev Bras Psiquiatr. 2008;30(2):149–151. doi:10.1590/S1516-44462008005000010
   PubMed Web of Science ®Google Scholar
• Gurel SC, Ozden HC, Karahan S, Ayhan Y. The superiority of ketofol and etomidate against propofol or thiopental anesthesia for ECT. Asian J Phsych. 2022;72:103090. doi:10.1016/j.ajp.2022.103090
   PubMedGoogle Scholar
• Wojdacz R, Święcicki Ł, Antosik-Wójcińska A. Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT. Psychiatria Polska. 2017;51(6):1039–1058. doi:10.12740/PP/75635
   PubMed Web of Science ®Google Scholar
• Wang N, Wang XH, Lu J, Zhang JY. The Effect of Repeated Etomidate Anesthesia on Adrenocortical Function During a Course of Electroconvulsive Therapy. J ECT. 2011;27(4):281–285. doi:10.1097/YCT.0b013e3182182be0
   PubMedGoogle Scholar
• Chawla N. Anesthesia for Electroconvulsive Therapy. Anes clini. 2020;38(1):183–195. doi:10.1016/j.anclin.2019.10.007
   PubMedGoogle Scholar
• Millischer V, Pramhas S, Wiedermann I, et al. Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: a retrospective analysis of seizure quality and safety. J Affective Disorders. 2023;330:33–39. doi:10.1016/j.jad.2023.02.085
   PubMedGoogle Scholar
• Fond G, Bennabi D, Haffen E, et al. A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression. Sci Rep. 2016;6(1):19847. doi:10.1038/srep19847
   PubMedGoogle Scholar
• Vaidya PV, Anderson EL, Bobb A, Pulia K, Jayaram G, Reti I. A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy. J ect. 2012;28(1):14–19. doi:10.1097/YCT.0b013e31823a4220
   PubMedGoogle Scholar
• Bryson EO, Ahle GM, Liebman LS, et al. Dosing and effectiveness of ketamine anesthesia for electroconvulsive therapy (ECT): a case series. Australas Psychiatry. 2014;22(5):467–469. doi:10.1177/1039856214545547
   PubMedGoogle Scholar
• Rybakowski JK, Bodnar A, Krzywotulski M, et al. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression. J ECT. 2016;32(3):164–168. doi:10.1097/YCT.0000000000000317
   PubMedGoogle Scholar
• Kelkar V, Gaddam N, Kulkarni S, Joshi P, Bhale P. A comparative study of propofol, thiopentone sodium, and ketofol as induction agents for electro convulsive therapy. J Anaesthesiol Clin Pharmacol. 2021;37(4):1.
   PubMedGoogle Scholar
• Delgado-Herrera L, Ostroff RD, Rogers SA. Sevoflurane:Approaching the Ideal Inhalational Anesthetic. A Pharmacologic, Pharmacoeconomic, and Clinical Review. CNS Drug Rev. 2001;7(1):48–120. doi:10.1111/j.1527-3458.2001.tb00190.x
   PubMedGoogle Scholar
• Rasmussen KG, Spackman TN, Hooten WM. The Clinical Utility of Inhalational Anesthesia With Sevoflurane in Electroconvulsive Therapy. J ECT. 2005;21(4):239–242. doi:10.1097/01.yct.0000180469.30712.90
   PubMedGoogle Scholar
• Toprak HI, Gedik E, Begeç Z, Oztürk E, Kaya B, Ersoy MO. Sevoflurane as an Alternative Anaesthetic for Electroconvulsive Therapy. J ECT. 2005;21(2):108–110. doi:10.1097/01.yct.0000166633.73555.28
   PubMedGoogle Scholar
• Aoki N, Suwa T, Kawashima H, et al. Sevoflurane in electroconvulsive therapy: a systematic review and meta-analysis of randomised trials. J Psychiatr Res. 2021;141:16–25. doi:10.1016/j.jpsychires.2021.06.030
   PubMedGoogle Scholar
• Milne B. Nitrous oxide (laughing gas) inhalation as an alternative to electroconvulsive therapy. Med Hypotheses. 2010;74(5):780–781. doi:10.1016/j.mehy.2009.11.021
   PubMedGoogle Scholar
• Lee K, Sparkle T. Use of Nitrous Oxide to Facilitate Induction for Electroconvulsive Therapy: a Case Report. Am J Case Rep. 2020;1:21.
   Google Scholar
• Mirzakhani H, Guchelaar H-J, Welch CA, et al. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: a Prospective, Randomized, Crossover Trial. Anesthesia Analg. 2016;123(3):587–596. doi:10.1213/ANE.0000000000001218
   PubMedGoogle Scholar
• Nazemroaya B, Ghosouri A, Honarmand A, Hashemi S. Comparison of hemodynamic changes and serum potassium levels in the use of succinylcholine and cisatracurium in electroconvulsive therapy. J Res Med Sci. 2021;26(1):106. doi:10.4103/jrms.JRMS_951_19
   PubMedGoogle Scholar
• Booij LH. Is succinylcholine appropriate or obsolete in the intensive care unit? Critical Care. 2001;5(5):245–246. doi:10.1186/cc1039
   PubMedGoogle Scholar
• Saricicek V, Sahin L, Bulbul F, Ucar S, Sahin M. Does Rocuronium-Sugammadex Reduce Myalgia and Headache After Electroconvulsive Therapy in Patients With Major Depression? J ECT. 2014;30(1):30–34. doi:10.1097/YCT.0b013e3182972bd2
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C. Effects of Propofol and Ketamine as Combined Anesthesia for Electroconvulsive Therapy in Patients With Depressive Disorder. J ECT. 2012;28(2):128–132. doi:10.1097/YCT.0b013e31824d1d02
   PubMed Web of Science ®Google Scholar
• Shams T, El-Masry R. Ketofol-Dexmedetomidine combination in ECT: a punch for depression and agitation. Indian Jl Anaes. 2014;58(3):275. doi:10.4103/0019-5049.135037
   PubMedGoogle Scholar
• Gasteiger L, Heil M, Hörner E, et al. Relationship Between Anesthesia Depth and Quality of Seizures in Patients Undergoing Electroconvulsive Therapy. J ECT. 2022;38(1):62–67. doi:10.1097/YCT.0000000000000792
   PubMedGoogle Scholar
• Andrew D. K, Weiner RD, Dean MD, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci. 2003;15(1):27–34. doi:10.1176/jnp.15.1.27
   PubMedGoogle Scholar
• Ikiz C, Gunenc F, Iyilikci L, et al. Effects of Propofol and Propofol-Remifentanil Combinations on Haemodynamics, Seizure Duration and Recovery during Electroconvulsive Therapy. Turk J Anaesthesiol Reanim. 2021;49(1):44–51. doi:10.5152/TJAR.2020.157
   PubMedGoogle Scholar
• Akcaboy ZN, Akcaboy EY, Yigitbas B, et al. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaes Scand. 2005;49(8):1068–1071. doi:10.1111/j.1399-6576.2005.00766.x
   PubMedGoogle Scholar
• Taylor R, Wark H, Leyden J, et al. Effects of the Anaesthetic-ECT time interval and ventilation rate on seizure quality in electroconvulsive therapy: a prospective randomised trial. Brain Stimulation. 2020;13(2):450–456. doi:10.1016/j.brs.2019.12.012
   PubMedGoogle Scholar
• Gálvez V, Hadzi-Pavlovic D, Wark H, Harper S, Leyden J, Loo CK. The Anaesthetic-ECT Time Interval in Electroconvulsive Therapy Practice – is It Time to Time? Brain Stimulation. 2016;9(1):72–77. doi:10.1016/j.brs.2015.09.005
   PubMedGoogle Scholar
• Haji Seyed Javadi A, Najafian E, Kayalha H, Shafikhani AA. Evaluating Factors Affecting the Time Interval Between Propofol Injection and Induction of Electro-convulsion and Relationship Between These Factors and Duration of Convulsion. Anesth Pain Medi. 2021;11(4). doi:10.5812/aapm.117442
   PubMedGoogle Scholar
• Gunawardane PO, Murphy PA, Sleigh JW. Bispectral index monitoring during electroconvulsive therapy under propofol anaesthesia. Br J Anaesth. 2002;88(2):184–187. doi:10.1093/bja/88.2.184
   PubMedGoogle Scholar
• Liu -C-C, Qian X-Y, J-X A, et al. Electroconvulsive Therapy Under General Anesthesia With Cisatracurium, Laryngeal Mask Airways, and Bispectral Index. J ECT. 2016;32(1):17–19. doi:10.1097/YCT.0000000000000251
   PubMedGoogle Scholar
• Gombar S, Aggarwal D, Khanna AK, Gombar KK, Chavan BS. The bispectral electroencephalogram during modified electroconvulsive therapy under propofol anesthesia: relation with seizure duration and awakening. J ect. 2011;27(2):114–118. doi:10.1097/YCT.0b013e3181df4ebb
   PubMedGoogle Scholar
• White PF, Rawal S, Recart A, Thornton L, Litle M, Stool L. Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy? Anesthesia Analg. 2003;96(6):1636–1639. doi:10.1213/01.ANE.0000066018.13553.08
   PubMedGoogle Scholar
• Simpson KH, Halsall PJ, Carr CM, Stewart KG. Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapy. Br J Anaesth. 1988;61(3):343–344. doi:10.1093/bja/61.3.343
   PubMedGoogle Scholar
• Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia Analg. 1995;81(3):596–602.
   PubMed Web of Science ®Google Scholar
• Nishihara F, Saito S. Pre-ictal bispectral index has a positive correlation with seizure duration during electroconvulsive therapy. Anesthesia Analg. 2002;94(5):1249–1252. (). doi:10.1097/00000539-200205000-00037
   PubMedGoogle Scholar
• Mayur P, Bray A, Fernandes J, Bythe K, Gilbett D. Impact of hyperventilation on stimulus efficiency during the early phase of an electroconvulsive therapy course: a randomized double-blind study. J ECT. 2010;26(2):91–94. doi:10.1097/YCT.0b013e3181c18901
   PubMedGoogle Scholar
• Aksay SS, Bumb JM, Janke C, Hoyer C, Kranaster L, Sartorius A. New evidence for seizure quality improvement by hyperoxia and mild hypocapnia. J ect. 2014;30(4):287–291. doi:10.1097/YCT.0000000000000109
   PubMedGoogle Scholar
• Haeck M, Gillmann B, Janouschek H, Grözinger M. Electroconvulsive therapy can benefit from controlled hyperventilation using a laryngeal mask. European Arch Psych Clini Neuros. 2011;261 Suppl 2:S172–176.
   PubMedGoogle Scholar
• de Arriba-Arnau A, Dalmau A, Soria V, et al. Protocolized hyperventilation enhances electroconvulsive therapy. J Affective Disorders. 2017;217:225–232. doi:10.1016/j.jad.2017.04.007
   PubMedGoogle Scholar
• Jonker Y, Rutten DJ, van Exel ER, et al. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange During Electroconvulsive Therapy. J ECT. 2019;35(2):110–114. doi:10.1097/YCT.0000000000000556
   PubMedGoogle Scholar
• Vaithialingam B, Bansal S, Muthuchellappan R, Thirthalli J, Chakrabarti D, Venkatapura RJ. Comparison of hands-free Trans-nasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) with conventional facemask ventilation technique for oxygenation in patients undergoing electroconvulsive therapy - A cross over study. Asian J Phsych. 2023;88:103734. doi:10.1016/j.ajp.2023.103734
   PubMedGoogle Scholar
• Dinwiddie SH, Huo D, Gottlieb O. The Course of Myalgia and Headache After Electroconvulsive Therapy. J ECT. 2010;26(2):116–120. doi:10.1097/YCT.0b013e3181b07c0a
   PubMedGoogle Scholar
• Karaaslan E, Akbas S, Ozkan AS, Zayman EP. Effects of preemptive intravenous paracetamol and ibuprofen on headache and myalgia in patients after electroconvulsive therapy. Medicine. 2019;98(51):e18473. doi:10.1097/MD.0000000000018473
   PubMedGoogle Scholar
• T-C L, Shiah IS, Sun C-J, Tzang R-F, Huang K-C, Lee W-K. Mirtazapine Relieves Post-Electroconvulsive Therapy Headaches and Nausea. J ECT. 2011;27(2):165–167. doi:10.1097/YCT.0b013e3181e63346
   PubMedGoogle Scholar
• Haghighi M, Sedighinejad A, Naderi Nabi B, et al. The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT). Anesth Pain Medi. 2016;6(3). doi:10.5812/aapm.33724.
   Google Scholar
• Andrade C, Arumugham SS, Thirthalli J. Adverse Effects of Electroconvulsive Therapy. Psychiat Clin North Am. 2016;39(3):513–530. doi:10.1016/j.psc.2016.04.004
   PubMed Web of Science ®Google Scholar
• Andrade C. Skeletal and Dental Fractures Associated With Electroconvulsive Therapy. J Clini Psych. 2023;84(1). doi:10.4088/JCP.23f14797
   Google Scholar
• Andreas D, Maleczek M, Panjikaran B, Herkner H, Karrison T, Nagele P. Major Adverse Cardiac Events and Mortality Associated with Electroconvulsive Therapy: a Systematic Review and Meta-analysis Perioperative Medicine. Anesthesiology. 2019;130(1):83–91. doi:10.1097/ALN.0000000000002488
   PubMedGoogle Scholar
• Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy: current concepts. N Engl J Med. 2009;360(14):1437–1444. doi:10.1056/NEJMra0707755
   PubMed Web of Science ®Google Scholar
• Sato Y, Takahashi H, Miyabe M, Toyooka H. Case of premature ventricular contraction immediately after electroconvulsive therapy in a depressive patient. Masui Japanese J Anes. 2005;54(1):46–48.
   PubMedGoogle Scholar
• Andrade C, Bolwig TG. Electroconvulsive Therapy, Hypertensive Surge, Blood-Brain Barrier Breach, and Amnesia. J ECT. 2014;30(2):160–164. doi:10.1097/YCT.0000000000000133
   PubMedGoogle Scholar
• Singh S, Jolly A. Does electroconvulsive therapy cause brain damage: an update. Indian J Psych. 2020;62(4):339. doi:10.4103/psychiatry.IndianJPsychiatry_239_19
   PubMedGoogle Scholar
• Lomas M, Rickard V, Milton F, Savage S, Weir A, Zeman A. Electroconvulsive therapy related autobiographical amnesia: a review and case report. Cogn Neuro. 2021;26(2):107–121. doi:10.1080/13546805.2021.1871889
   Google Scholar
• Anderson IM, McAllister-Williams RH, Downey D, Elliott R, Loo C. Cognitive function after electroconvulsive therapy for depression: relationship to clinical response. Psychological Medicine. 2020;51(10):1647–1656. doi:10.1017/S0033291720000379
   PubMedGoogle Scholar
• M. fraser L, O’Carroll RE, Klaus PE. The Effect of Electroconvulsive Therapy on Autobiographical Memory: a Systematic Review. J ECT. 2008;24(1):10–17. doi:10.1097/YCT.0b013e3181616c26
   PubMedGoogle Scholar
• Qiu Z, Zhou S, Zhang M, et al. Preventive effect of dexmedetomidine on postictal delirium after electroconvulsive therapy. European J Anaes. 2020;37(1):5–13. doi:10.1097/EJA.0000000000001113
   PubMedGoogle Scholar
• Kikuchi A, Yasui‐Furukori N, Fujii A, Katagai H, Kaneko S. Identification of predictors of post‐ictal delirium after electroconvulsive therapy. Psych Clin Neurosci. 2009;63(2):180–185. doi:10.1111/j.1440-1819.2009.01930.x
   PubMedGoogle Scholar